Felzartamab in Late Antibody-Mediated Rejection

Clinical trial NCT05021484 · COMPLETED

Trial details

NCT number: NCT05021484
Sponsor: Farsad Eskandary
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Antibody-mediated Rejection

Start date: 2021-10-06
Primary completion: 2024-03-07
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.